Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine
- PMID: 8981969
- PMCID: PMC1712555
Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine
Similar articles
-
Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine.J Clin Endocrinol Metab. 1998 Feb;83(2):487-91. doi: 10.1210/jcem.83.2.4529. J Clin Endocrinol Metab. 1998. PMID: 9467562
-
Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.Hum Mol Genet. 1994 Aug;3(8):1259-62. doi: 10.1093/hmg/3.8.1259. Hum Mol Genet. 1994. PMID: 7987299
-
RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Horm Res. 1997;47(4-6):168-78. doi: 10.1159/000185461. Horm Res. 1997. PMID: 9167949 Review.
-
Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.Am J Med. 1996 Dec;101(6):635-41. doi: 10.1016/s0002-9343(96)00330-0. Am J Med. 1996. PMID: 9003111
-
[From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].Ned Tijdschr Geneeskd. 2001 Nov 17;145(46):2217-21. Ned Tijdschr Geneeskd. 2001. PMID: 11757244 Review. Dutch.
Cited by
-
Neuroendocrine Tumors: Genomics and Molecular Biomarkers with a Focus on Metastatic Disease.Cancers (Basel). 2023 Apr 12;15(8):2249. doi: 10.3390/cancers15082249. Cancers (Basel). 2023. PMID: 37190177 Free PMC article. Review.
-
Medullary thyroid cancer and pheochromocytoma in MEN2A: are there parent of origin effects on disease expression?Fam Cancer. 2022 Oct;21(4):473-478. doi: 10.1007/s10689-021-00282-w. Epub 2021 Oct 22. Fam Cancer. 2022. PMID: 34677728
-
Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.BMC Cancer. 2021 Apr 7;21(1):369. doi: 10.1186/s12885-021-08116-9. BMC Cancer. 2021. PMID: 33827484 Free PMC article.
-
Preimplantation Genetic Testing of Multiple Endocrine Neoplasia Type 2A.Front Endocrinol (Lausanne). 2020 Oct 14;11:572151. doi: 10.3389/fendo.2020.572151. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33178136 Free PMC article.
-
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study.Endocr Connect. 2020 Jun;9(6):489-497. doi: 10.1530/EC-20-0163. Endocr Connect. 2020. PMID: 32375120 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical